ANDA 40196, held by Chartwell Rx. Warfarin Sodium.
As of Nov 16, 2026, ANDA 40196 (Warfarin Sodium), held by Chartwell Rx, was first approved by FDA on Sep 30, 1997, with 10 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 30, 1997 | Original application | Approved | None posted |
| Warfarin Sodium1MG · tablet;oral | Warfarin Sodium | Discontinued |
| Warfarin Sodium2MG · tablet;oral | Warfarin Sodium | Discontinued |
| Warfarin Sodium2.5MG · tablet;oral | Warfarin Sodium | Discontinued |
| Warfarin Sodium4MG · tablet;oral | Warfarin Sodium | Discontinued |
| Warfarin Sodium5MG · tablet;oral | Warfarin Sodium | Discontinued |
| Warfarin Sodium7.5MG · tablet;oral | Warfarin Sodium | Discontinued |
| Warfarin Sodium10MG · tablet;oral | Warfarin Sodium | Discontinued |
| Warfarin Sodium3MG · tablet;oral | Warfarin Sodium | Discontinued |
| Warfarin Sodium6MG · tablet;oral | Warfarin Sodium | Discontinued |
| Apr 15, 2002 | Supplement 8Manufacturing | Approved | None posted |
| Apr 15, 2002 | Supplement 9Manufacturing | Approved | None posted |
| Apr 15, 2002 | Supplement 10Manufacturing | Approved | None posted |
| Jul 26, 2000 | Supplement 4Manufacturing | Approved | None posted |
| Jul 26, 2000 | Supplement 5Manufacturing | Approved | None posted |
| Jul 26, 2000 | Supplement 6Manufacturing | Approved | None posted |
| Jul 26, 2000 | Supplement 7Labeling | Approved | None posted |
| Feb 23, 2000 | Supplement 3Manufacturing | Approved | None posted |
| Jan 5, 2000 | Supplement 2Labeling | Approved | None posted |
| Oct 8, 1998 | Supplement 1Manufacturing | Approved | None posted |
| Sep 30, 1997 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters